Seebri and Bronchitis - a phase IV clinical study of FDA data
Summary:
Bronchitis is reported as a side effect among people who take Seebri (glycopyrrolate), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Xolair, and have Asthma.
The phase IV clinical study analyzes which people have Bronchitis when taking Seebri. It is created by eHealthMe based on reports of 2,613 people who have side effects when taking Seebri from the FDA, and is updated regularly.
What is Seebri?
Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.
What is Bronchitis?
Bronchitis (inflammation of the mucous membrane in the bronchial tubes) is found to be associated with 2,325 drugs and 2,440 conditions by eHealthMe. Check the latest studies of Bronchitis.
2,613 people reported to have side effects when taking Seebri.
Among them, 170 people (6.51%) have Bronchitis.
Among these 170 people:
How long have people been on Seebri when they have Bronchitis? *
What is the gender of people who have Bronchitis when taking Seebri? *
What is the age of people who have Bronchitis when taking Seebri? *
What are other drugs people take besides Seebri? *
What are other side effects people have besides Bronchitis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Seebri and have Bronchitis?
- Check whether Bronchitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Seebri:
- Seebri (2,618 reports)
Bronchitis treatments and more:
- Bronchitis (118,921 reports)
How severe was Bronchitis and when was it recovered:
Expand to all the drugs that have ingredients of glycopyrrolate:
- Bronchitis and drugs with ingredients of glycopyrrolate (428 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Seebri:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bronchitis:
- Bronchitis (2,325 drugs)
Browse all the conditions that are associated with Bronchitis:
- Bronchitis (2,440 conditions)
Related publications that referenced our studies
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Seebri) and Seebri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Halflytely and Levaquin - a second ago
- Could Catapres cause Blood Lactate Dehydrogenase Increased? - 4 seconds ago
- Type 2 Diabetes and drugs of ingredients of atorvastatin calcium; ezetimibe - 5 seconds ago
- Diabetes Mellitus Non-Insulin-Dependent and drugs of ingredients of atorvastatin calcium; ezetimibe - 5 seconds ago
- Dry Eyes in Pregabalin, how severe and when it was recovered? - 17 seconds ago
- Drug interactions of Altace and Mucinex - 20 seconds ago
- Could Inbrija cause Abdominal Pain? - 30 seconds ago
- Drug interactions of Mg and Meloxicam - 41 seconds ago
- Sulfasalazine and Breast Cancer Stage Iii for Women aged 40-49 - 43 seconds ago
- Could Gabapentin cause Pressure Ulcer? - 44 seconds ago